People · Operator

Norifumi E. Nakamura

Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals

1
Companies
1
Filings
$51.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Topica Pharmaceuticals IncPharmaceuticalsSeries B$51.5M$1.1B2011
Operator network

Norifumi E. Nakamura at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Alex Gregory Barkas · 1 companies · 1 sharedAlex Gregory Bark…Catherine E. De Porceri-Morton · 1 companies · 1 sharedCatherine E. De P…Charles Gregory Homcy MD · 1 companies · 1 sharedCharles Gregory H…Charles Gregory Vontz · 1 companies · 1 sharedCharles Gregory V…David E. Cohen MD MPH · 1 companies · 1 sharedDavid E. Cohen MD…David Kirk Cohen, MD · 1 companies · 1 sharedDavid Kirk Cohen,…G. Kirk Raab · 1 companies · 1 sharedG. Kirk RaabJoseph E. Golemme · 1 companies · 1 sharedJoseph E. GolemmeJoseph Kirk Golemme · 1 companies · 1 sharedJoseph Kirk Golem…Russell Gregory Hirsch, MD, Ph.D. · 1 companies · 1 sharedRussell Gregory H…Topica Pharmaceuticals Inc · $51.5M raisedTopica Pharmaceutical…Norifumi E. NakamuraNN
Norifumi E. Nakamura Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Norifumi E. Nakamura on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Charles Gregory Homcy MD11
Joseph E. Golemme11
Charles Gregory Vontz11
G. Kirk Raab11
Alex Gregory Barkas11
Catherine E. De Porceri-Morton11
David E. Cohen MD MPH11
Russell Gregory Hirsch, MD, Ph.D.11
Joseph Kirk Golemme11
David Kirk Cohen, MD11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.